Facially amphiphilic polyaryl and polyarylalkynyl polymers and oligomers and uses thereof

Details for Australian Patent Application No. 2005208771 (hide)

Owner The Trustees of the University of Pennsylvania

Inventors Tew, Gregory N.; Liu, Dahui; Degrado, William F.; Klein, Michael L.

Agent Davies Collison Cave

Pub. Number AU-B-2005208771

PCT Pub. Number WO2005/072246

Priority 60/538,270 23.01.04 US

Filing date 21 January 2005

Wipo publication date 11 August 2005

Acceptance publication date 24 November 2011

International Classifications

C07C 211/00 (2006.01) Compounds containing amino groups bound to a carbon skeleton

A61K 31/135 (2006.01) - having aromatic rings, e.g. methadone

C07C 211/27 (2006.01) Compounds containing amino groups bound to a carbon skeleton

C07C 217/58 (2006.01) Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton

C07C 233/78 (2006.01) Carboxylic acid amides

C07C 279/12 (2006.01) Derivatives of guanidine, i.e. compounds containing the group the singly-bound nitrogen atoms not being part of nitro or nitroso groups

Event Publications

7 September 2006 PCT application entered the National Phase

  PCT publication WO2005/072246 Priority application(s): WO2005/072246

14 May 2009 Assignment before Grant

  Liu, Dahui; The Trustees of the University of Pennsylvania; Klein, Michael; Tew, Gregory; Degrado, William The application has been assigned to The Trustees of the University of Pennsylvania

24 November 2011 Application Accepted

  Published as AU-B-2005208771

22 March 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005208775-Liquid supplement compositions comprising one or more medicaments

2005208766-Inhibition of Bright function as a treatment for excessive immunoglobulin production